Showing results (1001-1010 of 1,557) with videos related to
Sort By:
Pageof 156
Therapeutic Advances in Gastroenterology|March 14, 2017
Everolimus in the management of metastatic neuroendocrine tumoursDavid L Chan, Eva Segelov, Simron SinghTherapeutic Advances in Gastroenterology|March 14, 2017
Gastrointestinal manifestations of mitochondrial disorders: a systematic reviewJosef Finsterer, Marlies FrankTherapeutic Advances in Gastroenterology|February 17, 2017
Efficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre studyTakayuki Yamamoto, Toshiaki Tanaka, Tadashi Yokoyama, et al.Therapeutic Advances in Gastroenterology|February 17, 2017
Differences in the prognosis of early gastric cancer according to sex and ageDo Dam Suh, Seong Tae Oh, Jeong Hwan Yook, et al.Therapeutic Advances in Gastroenterology|February 17, 2017
Minimum absolute lymphocyte counts during radiation are associated with a worse prognosis in patients with unresectable hepatocellular carcinomaQianqian Zhao, Xiaoqing Xu, Jinbo Yue, et al.Therapeutic Advances in Gastroenterology|February 17, 2017
The role of dexlansoprazole modified-release in the management of gastroesophageal reflux diseaseRonnie Fass, Rosita FrazierTherapeutic Advances in Gastroenterology|February 17, 2017
Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practiceSusan Lucak, Lin Chang, Albena Halpert, et al.Therapeutic Advances in Gastroenterology|August 27, 2019
Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort StudyLuc Biedermann, Laura Renz, Nicolas Fournier, et al.Therapeutic Advances in Gastroenterology|July 20, 2019
Current status of first- and second-line Helicobacter pylori eradication therapy in the metropolitan area: a multicenter study with a large number of patientsHideki Mori, Hidekazu Suzuki, Fumio Omata, et al.Therapeutic Advances in Gastroenterology|October 23, 2018
Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel diseaseViktoria Bergqvist, Mohammad Kadivar, Daniel Molin, et al.Pageof 156